Skip to main content
. 2016 Jun 1;11(6):464–474. doi: 10.1080/15592294.2016.1151586

Table 2.

Correlations of DM loci and gene expression.

Comparison Gene name (DASL) TargetID (HM450) Relation to UCSC CpG Island Functional Location Enhancer Spearman, r Spearman, P-value
HBV vs HCV MFSD7 cg05827190 Island Body Enhancer -0.41 0.0315
HBV vs HCV FLNC cg02661879 Island 5'UTR;1stExon Non-enhancer -0.43 0.0221
HBV vs NIV ATF5 cg04315771 S_Shore TSS1500;5'UTR Non-enhancer -0.64 0.0003
HBV vs NIV KIAA1199 cg02585724 Opensea 5'UTR Enhancer 0.40 0.0357
HCV vs NIV AXIN2 cg09231741 Island Body Non-enhancer 0.45 0.0156
HCV vs NIV CES3 cg26538442 Opensea TSS200 Enhancer -0.48 0.0099
HCV vs NIV DHRS3 cg26029221 N_Shelf Body Enhancer -0.51 0.0054
HCV vs NIV HOXA6 cg23129930 Island 1stExon Non-enhancer 0.45 0.0161
HCV vs NIV IGFBP4 cg02627216 N_Shore TSS1500 Non-enhancer -0.44 0.0199
HCV vs NIV LRRC17 cg20066782 Opensea Body Enhancer -0.45 0.0169
HCV vs NIV RAB11FIP4 cg07146073 Opensea Body Enhancer 0.51 0.0055
HCV vs NIV ROR1 cg03937361 Opensea Body Enhancer 0.67 0.0001
HCV vs NIV ROR1 cg13942627 Opensea Body Enhancer 0.44 0.0193
HCV vs NIV SGIP1 cg09665332 Opensea Body Enhancer -0.52 0.0046
HCV vs NIV STEAP2 cg06112923 Opensea Body;3'UTR Non-enhancer 0.51 0.0057